RECURRENT HEAD AND NECK CARCINOMA
Clinical trials for RECURRENT HEAD AND NECK CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough head and neck cancer
Disease control OngoingThis study tests whether adding ramucirumab to pembrolizumab works better than pembrolizumab alone for people with advanced head and neck cancer that has come back or spread. About 37 adults with PD-L1 positive cancer will take part. The goal is to see if the combination shrinks …
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
New hope for head and neck cancer: which radiation works best?
Disease control TerminatedThis study is for people whose head and neck cancer has returned after previous radiation and who cannot have surgery. It compares two radiation techniques: a precise, short-course method (stereotactic body radiation therapy) and a standard longer-course method (intensity modulat…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:12 UTC
-
New combo therapy shows promise for HIV patients with advanced cancer
Disease control OngoingThis early-phase trial is testing the safety of combining two cancer drugs—nivolumab and cabozantinib—in people with HIV who have advanced solid tumors. The study includes 8 participants with various cancers that have spread. The goal is to see if the combination can shrink or st…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to standard therapy are enrolled. The goal is to see if targe…
Matched conditions: RECURRENT HEAD AND NECK CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 03:11 UTC